ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Poloxamer 188 Excipients Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-28Y16790
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Poloxamer 188 Excipients Market Research Report 2024
BUY CHAPTERS

Global Poloxamer 188 Excipients Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-28Y16790
Report
November 2025
Pages:118
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
BASF AG
CRODA
Hubei Hengshuo Chemical
Nanjing Well Pharmaceutical
CD Formulation

Poloxamer 188 Excipients Market

The global Poloxamer 188 Excipients market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Poloxamer 188 is a pharmaceutical excipient. It is a nonionic linear copolymer having an average molecular weight of 8400 Daltons and is also referred to as PLURONIC F68, FLOCOR and RheothRx. The copolymer was approved by the FDA nearly 50 years ago as a therapeutic reagent to reduce viscosity in the blood before transfusions.
From a downstream perspective, Injectable Formulation accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Poloxamer 188 Excipients leading manufacturers including BASF, Croda, Hubei Hengshuo Chemical, Nanjing Well Pharmaceutical, CD Formulation, etc., dominate supply; the top five capture approximately % of global revenue, with BASF leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Poloxamer 188 Excipients market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Poloxamer 188 Excipients Market Report

Report Metric Details
Report Name Poloxamer 188 Excipients Market
Segment by Type
  • Micronized Poloxamer 188
  • Ordinary Poloxamer 188
Segment by Application
  • Injectable Formulation
  • Oral Formulation
  • Topical Formulation
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company BASF, Croda, Hubei Hengshuo Chemical, Nanjing Well Pharmaceutical, CD Formulation
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Poloxamer 188 Excipients study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Poloxamer 188 Excipients Market report?

Ans: The main players in the Poloxamer 188 Excipients Market are BASF, Croda, Hubei Hengshuo Chemical, Nanjing Well Pharmaceutical, CD Formulation

What are the Application segmentation covered in the Poloxamer 188 Excipients Market report?

Ans: The Applications covered in the Poloxamer 188 Excipients Market report are Injectable Formulation, Oral Formulation, Topical Formulation

What are the Type segmentation covered in the Poloxamer 188 Excipients Market report?

Ans: The Types covered in the Poloxamer 188 Excipients Market report are Micronized Poloxamer 188, Ordinary Poloxamer 188

1 Study Coverage
1.1 Introduction to Poloxamer 188 Excipients: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Poloxamer 188 Excipients Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Micronized Poloxamer 188
1.2.3 Ordinary Poloxamer 188
1.3 Market Segmentation by Application
1.3.1 Global Poloxamer 188 Excipients Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Injectable Formulation
1.3.3 Oral Formulation
1.3.4 Topical Formulation
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Poloxamer 188 Excipients Revenue Estimates and Forecasts 2020-2031
2.2 Global Poloxamer 188 Excipients Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Poloxamer 188 Excipients Sales Estimates and Forecasts 2020-2031
2.4 Global Poloxamer 188 Excipients Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Poloxamer 188 Excipients Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Poloxamer 188 Excipients Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Micronized Poloxamer 188 Market Size by Manufacturers
3.5.2 Ordinary Poloxamer 188 Market Size by Manufacturers
3.6 Global Poloxamer 188 Excipients Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Poloxamer 188 Excipients Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Poloxamer 188 Excipients Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Poloxamer 188 Excipients Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Poloxamer 188 Excipients Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Poloxamer 188 Excipients Sales and Revenue by Type (2020-2031)
6.4 North America Poloxamer 188 Excipients Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Poloxamer 188 Excipients Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Poloxamer 188 Excipients Sales and Revenue by Type (2020-2031)
7.4 Europe Poloxamer 188 Excipients Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Poloxamer 188 Excipients Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Poloxamer 188 Excipients Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Poloxamer 188 Excipients Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Poloxamer 188 Excipients Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Poloxamer 188 Excipients Sales and Revenue by Type (2020-2031)
9.4 Central and South America Poloxamer 188 Excipients Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Poloxamer 188 Excipients Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Poloxamer 188 Excipients Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Poloxamer 188 Excipients Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Poloxamer 188 Excipients Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 BASF
11.1.1 BASF Corporation Information
11.1.2 BASF Business Overview
11.1.3 BASF Poloxamer 188 Excipients Product Models, Descriptions and Specifications
11.1.4 BASF Poloxamer 188 Excipients Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 BASF Poloxamer 188 Excipients Sales by Product in 2024
11.1.6 BASF Poloxamer 188 Excipients Sales by Application in 2024
11.1.7 BASF Poloxamer 188 Excipients Sales by Geographic Area in 2024
11.1.8 BASF Poloxamer 188 Excipients SWOT Analysis
11.1.9 BASF Recent Developments
11.2 Croda
11.2.1 Croda Corporation Information
11.2.2 Croda Business Overview
11.2.3 Croda Poloxamer 188 Excipients Product Models, Descriptions and Specifications
11.2.4 Croda Poloxamer 188 Excipients Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Croda Poloxamer 188 Excipients Sales by Product in 2024
11.2.6 Croda Poloxamer 188 Excipients Sales by Application in 2024
11.2.7 Croda Poloxamer 188 Excipients Sales by Geographic Area in 2024
11.2.8 Croda Poloxamer 188 Excipients SWOT Analysis
11.2.9 Croda Recent Developments
11.3 Hubei Hengshuo Chemical
11.3.1 Hubei Hengshuo Chemical Corporation Information
11.3.2 Hubei Hengshuo Chemical Business Overview
11.3.3 Hubei Hengshuo Chemical Poloxamer 188 Excipients Product Models, Descriptions and Specifications
11.3.4 Hubei Hengshuo Chemical Poloxamer 188 Excipients Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Hubei Hengshuo Chemical Poloxamer 188 Excipients Sales by Product in 2024
11.3.6 Hubei Hengshuo Chemical Poloxamer 188 Excipients Sales by Application in 2024
11.3.7 Hubei Hengshuo Chemical Poloxamer 188 Excipients Sales by Geographic Area in 2024
11.3.8 Hubei Hengshuo Chemical Poloxamer 188 Excipients SWOT Analysis
11.3.9 Hubei Hengshuo Chemical Recent Developments
11.4 Nanjing Well Pharmaceutical
11.4.1 Nanjing Well Pharmaceutical Corporation Information
11.4.2 Nanjing Well Pharmaceutical Business Overview
11.4.3 Nanjing Well Pharmaceutical Poloxamer 188 Excipients Product Models, Descriptions and Specifications
11.4.4 Nanjing Well Pharmaceutical Poloxamer 188 Excipients Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Nanjing Well Pharmaceutical Poloxamer 188 Excipients Sales by Product in 2024
11.4.6 Nanjing Well Pharmaceutical Poloxamer 188 Excipients Sales by Application in 2024
11.4.7 Nanjing Well Pharmaceutical Poloxamer 188 Excipients Sales by Geographic Area in 2024
11.4.8 Nanjing Well Pharmaceutical Poloxamer 188 Excipients SWOT Analysis
11.4.9 Nanjing Well Pharmaceutical Recent Developments
11.5 CD Formulation
11.5.1 CD Formulation Corporation Information
11.5.2 CD Formulation Business Overview
11.5.3 CD Formulation Poloxamer 188 Excipients Product Models, Descriptions and Specifications
11.5.4 CD Formulation Poloxamer 188 Excipients Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 CD Formulation Poloxamer 188 Excipients Sales by Product in 2024
11.5.6 CD Formulation Poloxamer 188 Excipients Sales by Application in 2024
11.5.7 CD Formulation Poloxamer 188 Excipients Sales by Geographic Area in 2024
11.5.8 CD Formulation Poloxamer 188 Excipients SWOT Analysis
11.5.9 CD Formulation Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Poloxamer 188 Excipients Industry Chain
12.2 Poloxamer 188 Excipients Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Poloxamer 188 Excipients Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Poloxamer 188 Excipients Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Poloxamer 188 Excipients Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Poloxamer 188 Excipients Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
BASF AG
CRODA
Hubei Hengshuo Chemical
Nanjing Well Pharmaceutical
CD Formulation
List of Tables
 Table 1. Global Poloxamer 188 Excipients Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Poloxamer 188 Excipients Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Poloxamer 188 Excipients Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Poloxamer 188 Excipients Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Poloxamer 188 Excipients Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Poloxamer 188 Excipients Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 7. Global Poloxamer 188 Excipients Sales by Region (2020-2025) & (Tons)
 Table 8. Global Poloxamer 188 Excipients Sales by Region (2026-2031) & (Tons)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Poloxamer 188 Excipients Sales by Manufacturers (2020-2025) & (Tons)
 Table 11. Global Poloxamer 188 Excipients Sales Share by Manufacturers (2020-2025)
 Table 12. Global Poloxamer 188 Excipients Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Poloxamer 188 Excipients Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Poloxamer 188 Excipients by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Poloxamer 188 Excipients as of 2024)
 Table 16. Global Poloxamer 188 Excipients Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Poloxamer 188 Excipients Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Ton)
 Table 18. Key Manufacturers Poloxamer 188 Excipients Manufacturing Base and Headquarters
 Table 19. Global Poloxamer 188 Excipients Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Poloxamer 188 Excipients Sales by Type (2020-2025) & (Tons)
 Table 23. Global Poloxamer 188 Excipients Sales by Type (2026-2031) & (Tons)
 Table 24. Global Poloxamer 188 Excipients Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global Poloxamer 188 Excipients Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global Poloxamer 188 Excipients ASP by Type (2020-2031) & (US$/Ton)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Poloxamer 188 Excipients Sales by Application (2020-2025) & (Tons)
 Table 29. Global Poloxamer 188 Excipients Sales by Application (2026-2031) & (Tons)
 Table 30. Poloxamer 188 Excipients High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Poloxamer 188 Excipients Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global Poloxamer 188 Excipients Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global Poloxamer 188 Excipients ASP by Application (2020-2031) & (US$/Ton)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America Poloxamer 188 Excipients Growth Accelerators and Market Barriers
 Table 37. North America Poloxamer 188 Excipients Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Poloxamer 188 Excipients Sales (Tons) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Poloxamer 188 Excipients Growth Accelerators and Market Barriers
 Table 40. Europe Poloxamer 188 Excipients Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Poloxamer 188 Excipients Sales (Tons) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Poloxamer 188 Excipients Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Poloxamer 188 Excipients Sales (Tons) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Poloxamer 188 Excipients Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Poloxamer 188 Excipients Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Poloxamer 188 Excipients Investment Opportunities and Key Challenges
 Table 47. Central and South America Poloxamer 188 Excipients Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Poloxamer 188 Excipients Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Poloxamer 188 Excipients Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. BASF Corporation Information
 Table 51. BASF Description and Major Businesses
 Table 52. BASF Product Models, Descriptions and Specifications
 Table 53. BASF Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 54. BASF Sales Value Proportion by Product in 2024
 Table 55. BASF Sales Value Proportion by Application in 2024
 Table 56. BASF Sales Value Proportion by Geographic Area in 2024
 Table 57. BASF Poloxamer 188 Excipients SWOT Analysis
 Table 58. BASF Recent Developments
 Table 59. Croda Corporation Information
 Table 60. Croda Description and Major Businesses
 Table 61. Croda Product Models, Descriptions and Specifications
 Table 62. Croda Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 63. Croda Sales Value Proportion by Product in 2024
 Table 64. Croda Sales Value Proportion by Application in 2024
 Table 65. Croda Sales Value Proportion by Geographic Area in 2024
 Table 66. Croda Poloxamer 188 Excipients SWOT Analysis
 Table 67. Croda Recent Developments
 Table 68. Hubei Hengshuo Chemical Corporation Information
 Table 69. Hubei Hengshuo Chemical Description and Major Businesses
 Table 70. Hubei Hengshuo Chemical Product Models, Descriptions and Specifications
 Table 71. Hubei Hengshuo Chemical Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 72. Hubei Hengshuo Chemical Sales Value Proportion by Product in 2024
 Table 73. Hubei Hengshuo Chemical Sales Value Proportion by Application in 2024
 Table 74. Hubei Hengshuo Chemical Sales Value Proportion by Geographic Area in 2024
 Table 75. Hubei Hengshuo Chemical Poloxamer 188 Excipients SWOT Analysis
 Table 76. Hubei Hengshuo Chemical Recent Developments
 Table 77. Nanjing Well Pharmaceutical Corporation Information
 Table 78. Nanjing Well Pharmaceutical Description and Major Businesses
 Table 79. Nanjing Well Pharmaceutical Product Models, Descriptions and Specifications
 Table 80. Nanjing Well Pharmaceutical Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 81. Nanjing Well Pharmaceutical Sales Value Proportion by Product in 2024
 Table 82. Nanjing Well Pharmaceutical Sales Value Proportion by Application in 2024
 Table 83. Nanjing Well Pharmaceutical Sales Value Proportion by Geographic Area in 2024
 Table 84. Nanjing Well Pharmaceutical Poloxamer 188 Excipients SWOT Analysis
 Table 85. Nanjing Well Pharmaceutical Recent Developments
 Table 86. CD Formulation Corporation Information
 Table 87. CD Formulation Description and Major Businesses
 Table 88. CD Formulation Product Models, Descriptions and Specifications
 Table 89. CD Formulation Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 90. CD Formulation Sales Value Proportion by Product in 2024
 Table 91. CD Formulation Sales Value Proportion by Application in 2024
 Table 92. CD Formulation Sales Value Proportion by Geographic Area in 2024
 Table 93. CD Formulation Poloxamer 188 Excipients SWOT Analysis
 Table 94. CD Formulation Recent Developments
 Table 95. Key Raw Materials Distribution
 Table 96. Raw Materials Key Suppliers
 Table 97. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 98. Milestones in Production Technology Evolution
 Table 99. Distributors List
 Table 100. Market Trends and Market Evolution
 Table 101. Market Drivers and Opportunities
 Table 102. Market Challenges, Risks, and Restraints
 Table 103. Research Programs/Design for This Report
 Table 104. Key Data Information from Secondary Sources
 Table 105. Key Data Information from Primary Sources


List of Figures
 Figure 1. Poloxamer 188 Excipients Product Picture
 Figure 2. Global Poloxamer 188 Excipients Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Micronized Poloxamer 188 Product Picture
 Figure 4. Ordinary Poloxamer 188 Product Picture
 Figure 5. Global Poloxamer 188 Excipients Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Injectable Formulation
 Figure 7. Oral Formulation
 Figure 8. Topical Formulation
 Figure 9. Poloxamer 188 Excipients Report Years Considered
 Figure 10. Global Poloxamer 188 Excipients Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Poloxamer 188 Excipients Revenue (2020-2031) & (US$ Million)
 Figure 12. Global Poloxamer 188 Excipients Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 13. Global Poloxamer 188 Excipients Revenue Market Share by Region (2020-2031)
 Figure 14. Global Poloxamer 188 Excipients Sales (2020-2031) & (Tons)
 Figure 15. Global Poloxamer 188 Excipients Sales (CAGR) by Region (2020-2031) (Tons)
 Figure 16. Global Poloxamer 188 Excipients Sales Market Share by Region (2020-2031)
 Figure 17. Top 5 and Top 10 Manufacturers Poloxamer 188 Excipients Sales Volume Market Share in 2024
 Figure 18. Global Poloxamer 188 Excipients Revenue Market Share Ranking (2024)
 Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 20. Micronized Poloxamer 188 Revenue Market Share by Manufacturer in 2024
 Figure 21. Ordinary Poloxamer 188 Revenue Market Share by Manufacturer in 2024
 Figure 22. Global Poloxamer 188 Excipients Sales Market Share by Type (2020-2031)
 Figure 23. Global Poloxamer 188 Excipients Revenue Market Share by Type (2020-2031)
 Figure 24. Global Poloxamer 188 Excipients Sales Market Share by Application (2020-2031)
 Figure 25. Global Poloxamer 188 Excipients Revenue Market Share by Application (2020-2031)
 Figure 26. North America Poloxamer 188 Excipients Sales YoY (2020-2031) & (Tons)
 Figure 27. North America Poloxamer 188 Excipients Revenue YoY (2020-2031) & (US$ Million)
 Figure 28. North America Top 5 Manufacturers Poloxamer 188 Excipients Sales Revenue (US$ Million) in 2024
 Figure 29. North America Poloxamer 188 Excipients Sales Volume (Tons) by Type (2020- 2031)
 Figure 30. North America Poloxamer 188 Excipients Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 31. North America Poloxamer 188 Excipients Sales Volume (Tons) by Application (2020-2031)
 Figure 32. North America Poloxamer 188 Excipients Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 33. US Poloxamer 188 Excipients Revenue (2020-2031) & (US$ Million)
 Figure 34. Canada Poloxamer 188 Excipients Revenue (2020-2031) & (US$ Million)
 Figure 35. Mexico Poloxamer 188 Excipients Revenue (2020-2031) & (US$ Million)
 Figure 36. Europe Poloxamer 188 Excipients Sales YoY (2020-2031) & (Tons)
 Figure 37. Europe Poloxamer 188 Excipients Revenue YoY (2020-2031) & (US$ Million)
 Figure 38. Europe Top 5 Manufacturers Poloxamer 188 Excipients Sales Revenue (US$ Million) in 2024
 Figure 39. Europe Poloxamer 188 Excipients Sales Volume (Tons) by Type (2020-2031)
 Figure 40. Europe Poloxamer 188 Excipients Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 41. Europe Poloxamer 188 Excipients Sales Volume (Tons) by Application (2020-2031)
 Figure 42. Europe Poloxamer 188 Excipients Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 43. Germany Poloxamer 188 Excipients Revenue (2020-2031) & (US$ Million)
 Figure 44. France Poloxamer 188 Excipients Revenue (2020-2031) & (US$ Million)
 Figure 45. U.K. Poloxamer 188 Excipients Revenue (2020-2031) & (US$ Million)
 Figure 46. Italy Poloxamer 188 Excipients Revenue (2020-2031) & (US$ Million)
 Figure 47. Russia Poloxamer 188 Excipients Revenue (2020-2031) & (US$ Million)
 Figure 48. Asia-Pacific Poloxamer 188 Excipients Sales YoY (2020-2031) & (Tons)
 Figure 49. Asia-Pacific Poloxamer 188 Excipients Revenue YoY (2020-2031) & (US$ Million)
 Figure 50. Asia-Pacific Top 8 Manufacturers Poloxamer 188 Excipients Sales Revenue (US$ Million) in 2024
 Figure 51. Asia-Pacific Poloxamer 188 Excipients Sales Volume (Tons) by Type (2020- 2031)
 Figure 52. Asia-Pacific Poloxamer 188 Excipients Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 53. Asia-Pacific Poloxamer 188 Excipients Sales Volume (Tons) by Application (2020-2031)
 Figure 54. Asia-Pacific Poloxamer 188 Excipients Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 55. Indonesia Poloxamer 188 Excipients Revenue (2020-2031) & (US$ Million)
 Figure 56. Japan Poloxamer 188 Excipients Revenue (2020-2031) & (US$ Million)
 Figure 57. South Korea Poloxamer 188 Excipients Revenue (2020-2031) & (US$ Million)
 Figure 58. China Taiwan Poloxamer 188 Excipients Revenue (2020-2031) & (US$ Million)
 Figure 59. India Poloxamer 188 Excipients Revenue (2020-2031) & (US$ Million)
 Figure 60. Central and South America Poloxamer 188 Excipients Sales YoY (2020-2031) & (Tons)
 Figure 61. Central and South America Poloxamer 188 Excipients Revenue YoY (2020-2031) & (US$ Million)
 Figure 62. Central and South America Top 5 Manufacturers Poloxamer 188 Excipients Sales Revenue (US$ Million) in 2024
 Figure 63. Central and South America Poloxamer 188 Excipients Sales Volume (Tons) by Type (2021-2031)
 Figure 64. Central and South America Poloxamer 188 Excipients Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 65. Central and South America Poloxamer 188 Excipients Sales Volume (Tons) by Application (2020-2031)
 Figure 66. Central and South America Poloxamer 188 Excipients Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 67. Brazil Poloxamer 188 Excipients Revenue (2020-2025) & (US$ Million)
 Figure 68. Argentina Poloxamer 188 Excipients Revenue (2020-2025) & (US$ Million)
 Figure 69. Middle East, and Africa Poloxamer 188 Excipients Sales YoY (2020-2031) & (Tons)
 Figure 70. Middle East and Africa Poloxamer 188 Excipients Revenue YoY (2020-2031) & (US$ Million)
 Figure 71. Middle East and Africa Top 5 Manufacturers Poloxamer 188 Excipients Sales Revenue (US$ Million) in 2024
 Figure 72. Middle East and Africa Poloxamer 188 Excipients Sales Volume (Tons) by Type (2021-2031)
 Figure 73. South America Poloxamer 188 Excipients Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 74. Middle East and Africa Poloxamer 188 Excipients Sales Volume (Tons) by Application (2020-2031)
 Figure 75. Middle East and Africa Poloxamer 188 Excipients Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 76. GCC Countries Poloxamer 188 Excipients Revenue (2020-2025) & (US$ Million)
 Figure 77. Turkey Poloxamer 188 Excipients Revenue (2020-2025) & (US$ Million)
 Figure 78. Egypt Poloxamer 188 Excipients Revenue (2020-2025) & (US$ Million)
 Figure 79. South Africa Poloxamer 188 Excipients Revenue (2020-2025) & (US$ Million)
 Figure 80. Poloxamer 188 Excipients Industry Chain Mapping
 Figure 81. Regional Poloxamer 188 Excipients Manufacturing Base Distribution (%)
 Figure 82. Global Poloxamer 188 Excipients Production Market Share by Region (2020-2031)
 Figure 83. Poloxamer 188 Excipients Production Process
 Figure 84. Regional Poloxamer 188 Excipients Production Cost Structure
 Figure 85. Channels of Distribution (Direct Vs Distribution)
 Figure 86. Bottom-up and Top-down Approaches for This Report
 Figure 87. Data Triangulation
 Figure 88. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Global Pharmaceutical Grade Poloxamers Market Research Report 2024
Poloxamer 184 Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pharmaceutical Thickener Excipients Market Research Report 2025
Global Pharmaceutical Polymer Excipients Market Research Report 2024
EO PO Block Copolymers Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pharmaceutical Grade Crospovidonum PVPP Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Polyoxidonium Market Insights Forecast to 2030
Pharmaceutical Grade Crospovidone Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pharmaceutical Lubricant Excipients Market Research Report 2025
Global Pharmaceutical Tween 80 Polysorbate 80 Market Research Report 2024
Global Perfluoroelastomer Polymer Market Research Report 2024
Global Pharmaceutical Excipients Market Research Report 2025
Global Water Soluble Polymers for Pharmaceutical Market Research Report 2024
Acetoxystyrene Monomer ASM Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
EO PO Copolymers Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pharmaceutical Excipients for Non injection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Thickener Excipients Market Research Report 2024
Pharmaceuticals and Excipients Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
High Purity Diisooctyl Phosphate P204 Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Polymer Excipients Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions